Foghorn Therapeutics Inc.
NASDAQ:FHTX

Watchlist Manager
Foghorn Therapeutics Inc. Logo
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Watchlist
Price: 5.4 USD -2% Market Closed
Market Cap: 301m USD
Have any thoughts about
Foghorn Therapeutics Inc.?
Write Note

Wall Street
Price Targets

FHTX Price Targets Summary
Foghorn Therapeutics Inc.

Wall Street analysts forecast FHTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FHTX is 10.78 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.

Lowest
Price Target
4.04 USD
25% Downside
Average
Price Target
10.78 USD
100% Upside
Highest
Price Target
14.7 USD
172% Upside
Foghorn Therapeutics Inc. Competitors:
Price Targets
688105
Nanjing Vazyme Biotech Co Ltd
7% Upside
INSM
Insmed Inc
15% Upside
AMRN
Amarin Corporation PLC
20% Downside
2171
CARsgen Therapeutics Holdings Ltd
52% Downside
302440
SK Bioscience Co Ltd
17% Downside
GLPG
Galapagos NV
16% Upside
VIR
Vir Biotechnology Inc
232% Upside
4584
Kidswell Bio Corporation
83% Upside

Revenue
Forecast

Revenue Estimate
Foghorn Therapeutics Inc.

The compound annual growth rate of Foghorn Therapeutics Inc.'s revenue for the next 3 years is 24%.

N/A
Past Growth
24%
Estimated Growth
Estimates Accuracy
-28%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Foghorn Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Foghorn Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FHTX's stock price target?
Price Target
10.78 USD

According to Wall Street analysts, the average 1-year price target for FHTX is 10.78 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.

What is Foghorn Therapeutics Inc.'s Revenue forecast?
Projected CAGR
24%

The compound annual growth rate of Foghorn Therapeutics Inc.'s revenue for the next 3 years is 24%.

Back to Top